Federal Register / Vol. 87, No. 109 / Tuesday, June 7, 2022 / Notices 34693 

1This burden estimate table refers to data 

collections at different time periods consistent with 

approved practice. The SCTOD contractor is 

working with respondents to reduce burden by 

submitting data using interoperability standards. 

These data collections may include OMB-approved 

forms. 

2The total number of transplant centers that 

submit data to the SCTOD is 177. 

3The Number of Responses per Respondent was 

calculated by dividing the Total Responses by the 

Number of Respondents and rounding to the nearest 

tenth. 

4The total number of responses is less than 

previous calculations because of improvements in 

estimation. Previous estimates assumed all years 

had the same number of transplants. This improved 

estimate includes accurate transplant counts from 

prior years, which are often less than the current 

year leading to less follow-up activity. 

5Total responses for Pre-Transplant Information 

Collection equals estimated number of new 

transplant patients in 2021. 

6Pre-transplant Data includes baseline recipient 

data including patient demographics, pertinent 

medical history, disease characteristics and status, 

and co-morbidities, transplant data procedure 

characteristics, including preparative regimen, and 

donor data. This number is rounded to nearest 

tenth. The actual burden estimate for these data is 

1.4175. 

7Transplant Procedure and Product Information 

equals estimated number of new transplant patients 

in 2021. 

8Transplant Procedure and Product Information 

includes Graft-vs-Host Disease (GVHD) prophylaxis, 

graft source, donor type and degree of HLA 

matching and graft manipulation; graft 

characteristic data for cord blood units, including 

infused cell dose; and product information. This 

number is rounded to nearest tenth. The actual 

burden estimate for these data is 1.0616. 

9The number of responses for Post-Transplant 

Periodic Information Collection is based on a 

predetermined schedule: 100 days after transplant, 

6 months after transplant, 1 year after transplant, 

annually for 6 years after transplant and then 

biennially thereafter. In any given year the number 

of responses is a function of the number of 

transplants in that year, the number of transplants 

in previous years, and expected patient survival 

between the time of transplant and any follow-up 

activity. 

10Post-Transplant Data Collection includes 

hematopoietic recovery and engraftment, serious 

complications including GVHD and second cancers, 

disease status, survival status, and cause of death; 

and subsequent procedures. This number is 

rounded to nearest tenth. The actual burden 

estimate is 0.5247. 

collected by the SCTOD to reflect 

current clinical care and facilitate 

statistical modeling throughout the 

approval period to fulfill the 

requirements of the Program. Such 

small incremental changes will not 

significantly affect the burden. Changes 

from the prior data collection 

spreadsheet include addition of a 

response option for pre-transplant 

information collection and three 

questions to collect donor lymphocyte 

infusion for post-transplant information 

collection. The burden has decreased 

due to better estimates of the number of 

responses and use of burden testing 

results to estimate the time required. 

A 60-day Notice published in the 

Federal Register, Volume 87, Number 

53, FR 15439–15440 (March 18, 2022). 

There were no public comments. 

Need and Proposed Use of the 

Information: Per statutory 

responsibilities, the collection of 

information outlined in the ‘‘Total 

Estimated Annualized Burden Hours’’ 

section below is needed to collect, 

analyze, and publish stem cell 

transplantation related data including 

patient outcomes data and provide the 

Secretary of HHS with an annual report 

of transplant center-specific survival 

data. The proposed revisions of this 

information collection reflect the most 

up-to-date medical evidence while 

simultaneously reducing HCT facility 

burden. Revisions fall into several 

categories: consolidating questions, 

implementing interactive requests 

(electronic check boxes, check all that 

apply and pull-down menus) to reduce 

data entry time, adding necessary 

information fields, adding clarity to 

information requests and removing 

items no longer clinically significant 

(e.g., drugs). These revisions also 

incorporate COVID–19 vaccine 

questions currently under emergency 

approval. From time to time, there may 

be refinements in the information 

collection to keep pace with changes in 

the field or to enhance the ability to 

collect information in an automated 

fashion from respondent source 

systems, such as electronic health 

records. The contractor requests OMB 

approval by June 30, 2022. 

Likely Respondents: Transplant 

Centers. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The revised total annual 

burden hours estimated for this ICR are 

summarized in the table below. The 

total hours decreased from 56,786 to 

51,526 due to minor changes in the ICR. 

TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS

Form name 1 Number of 

respondents 2

Number of 

responses per 

respondent 3

Total 

responses 4

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Pre-Transplant Information Collection ............................... 177 52.6 5 9,315 6 1.4 13,041 

Transplant Procedure and Product Information ................ 177 52.6 7 9,315 8 1.1 10,247 

Post-Transplant Periodic Information Collection based on 

Predetermined Schedule ................................................ 177 319.1 9 56,476 10 0.5 28,238 

Total ............................................................................ 177 .......................... 75,106 ........................ 51,526 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2022–12225 Filed 6–6–22; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 


jspears on DSK121TN23PROD with NOTICES1
34694 Federal Register / Vol. 87, No. 109 / Tuesday, June 7, 2022 / Notices 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; Early 

Phase Clinical Trials—Pharma/Device and K 

Awards. 

Date: July 1, 2022. 

Time: 12:00 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Rebecca Steiner Garcia, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

Neuroscience Center, 6001 Executive Blvd., 

Room 6149, MSC 9608, Bethesda, MD 20892– 

9608, 301–443–4525, steinerr@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; Pilot 

Effectiveness Trials of Interventions for 

Preschoolers with ADHD. 

Date: July 7, 2022. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Serena Chu, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

Neuroscience Center, 6001 Executive Blvd., 

Room 6000, MSC 9606, Bethesda, MD 20852, 

301–500–5829, serena.chu@nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

HEAL Related Interventions. 

Date: July 8, 2022. 

Time: 12:30 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Nicholas Gaiano, Ph.D., 

Review Branch Chief, Division of Extramural 

Activities, National Institute of Mental 

Health, National Institutes of Health, 

Neuroscience Center/Room 6150/MSC 9606, 

6001 Executive Boulevard, Bethesda, MD 

20892–9606, 301–443–2742, nick.gaiano@

nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Practice-Based Suicide Prevention Research 

Centers (P50). 

Date: July 14, 2022. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Serena Chu, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health 

Neuroscience Center, 6001 Executive Blvd., 

Room 6000, MSC 9606, Bethesda, MD 20852, 

301–500–5829, serena.chu@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: June 1, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–12155 Filed 6–6–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; Clinical Trials in Neurology. 

Date: June 27–28, 2022. 

Time: 8:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Shanta Rajaram, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

NINDS/NIH NSC, 6001 Executive Boulevard, 

Rockville, MD 20852, 301–435–6033, 

rajarams@mail.nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; BRAIN Initiative: Biology 

and Biophysics of Neural Stimulation and 

Recording Technologies. 

Date: June 27, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Virtual 

Meeting). 

Contact Person: Mirela Milescu, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

NINDS/NIH NSC, 6001 Executive Boulevard, 

Rockville, MD 20852, 301–496–5720, 

mirela.milescu@nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; Clinical Trial Readiness for 

Rare Neurological and Neuromuscular 

Diseases. 

Date: June 29, 2022. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Ana Olariu, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

NINDS/NIH, NSC, 6001 Executive Boulevard, 

Rockville, MD 20852, 301–496–9223, 

Ana.Olariu@nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; R13 Review. 

Date: July 6, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Li Jia, Ph.D., Scientific 

Review Officer, Scientific Review Branch, 

Division of Extramural Research, NINDS/ 

NIH, NSC, 6001 Executive Boulevard, 

Rockville, MD 20852, 301–451–2854, li.jia@

nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; NINDS R25 Programs. 

Date: July 11–12, 2022. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: DeAnna Lynn Adkins, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Research, NINDS/NIH, NSC, 6001 Executive 

Boulevard, Rockville, MD 20852, 301–496– 

9223, deanna.adkins@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 


jspears on DSK121TN23PROD with NOTICES1